United Therapeutics Unveils Its 2024 Corporate Responsibility Report
United Therapeutics Corporation (Nasdaq: UTHR), a well-known public benefit corporation, has made a noteworthy advancement by publishing its 2024 Corporate Responsibility and Public Benefit Report. This document outlines the company's progress over the past fiscal year and underscores their ongoing dedication to creating innovative solutions for their patients.
Progress Toward Patient-Centric Goals
Central to United Therapeutics' mission is their commitment to ensuring that no patient is overlooked. The report highlights the significant accomplishments achieved in the last year, largely fueled by their groundbreaking organ manufacturing initiatives. Christopher Causey, Chair of the Nominating and Governance Committee, expressed excitement about the company's growth trajectory, particularly noting the essential link between patient health and the well-being of our ecosystems. United Therapeutics aims to achieve its objectives while embracing innovative construction practices, including a target of net zero energy for new buildings.
Impact on Patient Care
In 2023, United Therapeutics made a positive difference for over 14,500 patients, showcasing their extensive service offerings. Among these patients, more than a hundred benefited from their centralized ex vivo lung perfusion (EVLP) service, highlighting the company’s commitment to improving transplant accessibility. Additionally, their patient assistance program has helped over 32,000 individuals access treatments since its launch, further demonstrating the company’s dedication to patient welfare.
Employee and Environmental Commitment
This commitment extends to their workforce as well; over 90% of United Therapeutics employees have expressed pride in being part of a company recognized as a great place to work. This reflects a supportive workplace culture that aligns with the company's objectives. On the sustainability front, around 26% of United Therapeutics' properties hold LEED certification, including their innovative warehouse designed to meet green building standards.
Advancements in Sustainability
United Therapeutics is making significant investments in renewable energy, including the operation of a 7-MW capacity onsite solar field, which underscores their dedication to environmental stewardship. James Edgemond, the company’s CFO, emphasized that recognizing the interconnectedness of various challenges allows United Therapeutics to effectively pursue their goals while balancing resources for the best possible outcomes.
New Corporate Responsibility Website
Alongside this report, United Therapeutics has launched an updated corporate responsibility website. This new platform includes additional sections designed to cater to stakeholder interests, featuring valuable resources and inspiring impact stories from employees, which further highlight the innovative spirit at United Therapeutics.
The Vision of United Therapeutics
United Therapeutics stands out as the first publicly traded biotech company structured as a public benefit corporation. Their mission revolves around creating a brighter future for patients through the development of novel pharmaceutical therapies and technologies aimed at increasing the availability of transplantable organs. This mission underscores their steadfast commitment to patient well-being and community health.
Frequently Asked Questions
What is United Therapeutics' main goal?
United Therapeutics aims to provide innovative pharmaceutical therapies and technology to enhance the availability of transplantable organs, ensuring no patient is left behind.
How many patients does United Therapeutics serve?
The company reported serving over 14,500 patients in 2023, demonstrating significant growth in their service offerings.
What sustainability efforts is United Therapeutics undertaking?
United Therapeutics has committed to energy-efficient practices, such as achieving LEED gold certification for their buildings and investing in onsite solar fields.
How does United Therapeutics support its employees?
With over 90% of employees stating that United Therapeutics is a great place to work, the company emphasizes a supportive and engaging workplace culture.
Where can I find additional resources about United Therapeutics?
For further information, check their updated corporate responsibility website, featuring valuable resources and impact stories illustrating their efforts.
